Le SIDA en Afrique subsaharienne (serveur d'exploration) - Analysis (RSA)

Index « Auteurs » - entrée « Gerald Friedland »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Gerald Chege < Gerald Friedland < Gerald H. Friedland  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000038 (2017) Nesri Padayatchi [Afrique du Sud] ; Naressa Naidu [Afrique du Sud] ; Gerald Friedland [États-Unis] ; Kasavan Naidoo [Afrique du Sud] ; Francesca Conradie [Afrique du Sud] ; Kogieleum Naidoo [Afrique du Sud] ; Max Roe O'Donnell [États-Unis]Turning the tide against tuberculosis.
000262 (2017) Sheela V. Shenoi ; Anthony P. Moll ; Ralph P. Brooks ; Tassos Kyriakides [États-Unis] ; Laurie Andrews ; Teja Kompala ; Devesh Upadhya [États-Unis] ; Frederick L. Altice ; Francois J. Eksteen [Afrique du Sud] ; Gerald FriedlandIntegrated Tuberculosis/Human Immunodeficiency Virus Community-Based Case Finding in Rural South Africa: Implications for Tuberculosis Control Efforts.
000647 (2015) Devesh Upadhya [États-Unis] ; Anthony P. Moll [Afrique du Sud] ; Ralph P. Brooks [États-Unis] ; Gerald Friedland [États-Unis] ; Sheela V. Shenoi [États-Unis]What motivates use of community-based human immunodeficiency virus testing in rural South Africa?
000E98 (2010) Salim S. Abdool Karim [Afrique du Sud] ; Kogieleum Naidoo ; Anneke Grobler ; Nesri Padayatchi ; Cheryl Baxter ; Andrew Gray ; Tanuja Gengiah ; Gonasagrie Nair ; Sheila Bamber ; Aarthi Singh ; Munira Khan ; Jacqueline Pienaar ; Wafaa El-Sadr ; Gerald Friedland ; Quarraisha Abdool KarimTiming of initiation of antiretroviral drugs during tuberculosis therapy.
000F11 (2010) Quarraisha Abdool Karim [Afrique du Sud] ; Salim S. Abdool Karim ; Cheryl Baxter ; Gerald Friedland ; Tanuja Gengiah ; Andrew Gray ; Anneke Grobler ; Kogileum Naidoo ; Nesri Padayatchi ; Wafaa El-SadrThe SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis.
001032 (2010) Scott K. Heysell [Afrique du Sud] ; Anthony P. Moll ; Neel R. Gandhi ; Francois J. Eksteen ; Palav Babaria ; Yacoob Coovadia ; Lynn Roux ; Umesh Lalloo ; Gerald Friedland ; N Sarita ShahExtensively drug-resistant Mycobacterium tuberculosis from aspirates, Rural South Africa.
001087 (2010) Scott K. Heysell [Afrique du Sud] ; Tania A. Thomas ; Neel R. Gandhi ; Anthony P. Moll ; François J. Eksteen ; Yacoob Coovadia ; Lynette Roux ; Palav Babaria ; Umesh Lalloo ; Gerald Friedland ; Sarita ShahBlood cultures for the diagnosis of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected patients from rural South Africa: a cross-sectional study.
001435 (2007) Gerald Friedland [États-Unis] ; Gavin J. Churchyard [Afrique du Sud, Royaume-Uni] ; Edward Nardell [États-Unis]Tuberculosis and HIV Coinfection: Current State of Knowledge and Research Priorities
001444 (2007) Jason R. Andrews [États-Unis] ; N. Sarita Shah [États-Unis] ; Neel Gandhi [États-Unis] ; Tony Moll [Afrique du Sud] ; Gerald Friedland [États-Unis]Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Implications for the HIV Epidemic and Antiretroviral Therapy Rollout in South Africa
001566 (2005) Edana Cassol ; Anisa Mosam [Afrique du Sud] ; Gerald Friedland [États-Unis] ; Hoosen M. CoovadiaReply to Tayloe
001631 (2004) Gerald Friedland [États-Unis] ; Salim Abdool Karim [Afrique du Sud] ; Quarraisha Abdool Karim [Afrique du Sud] ; Umesh Lalloo [Afrique du Sud] ; Christopher Jack [Afrique du Sud] ; Neel Gandhi [États-Unis] ; Wafaa El Sadr [États-Unis]Utility of Tuberculosis Directly Observed Therapy Programs as Sites for Access to and Provision of Antiretroviral Therapy in Resource-Limited Countries

List of associated KwdEn.i

Nombre de
documents
Descripteur
5HIV Infections (complications)
5Humans
4Adult
4Female
4Male
3HIV Infections (drug therapy)
2AIDS-Related Opportunistic Infections (microbiology)
2Antitubercular Agents (therapeutic use)
2Drug Therapy, Combination
2Middle Aged
2Mycobacterium tuberculosis (isolation & purification)
2Rural Population
2South Africa
2Tuberculosis (drug therapy)
2Young Adult
1AIDS-Related Opportunistic Infections (blood)
1AIDS-Related Opportunistic Infections (complications)
1AIDS-Related Opportunistic Infections (diagnosis)
1AIDS-Related Opportunistic Infections (drug therapy)
1AIDS-Related Opportunistic Infections (mortality)
1Adolescent
1Anti-Retroviral Agents (administration & dosage)
1Anti-Retroviral Agents (adverse effects)
1Anti-Retroviral Agents (therapeutic use)
1Antitubercular Agents (administration & dosage)
1Antitubercular Agents (adverse effects)
1Antitubercular Agents (pharmacology)
1Biomedical Research
1Biopsy, Fine-Needle (methods)
1CD4 Lymphocyte Count
1Child
1Child, Preschool
1Clinical Trials as Topic (methods)
1Cross-Sectional Studies
1Culture Media
1Drug Administration Schedule
1Drug Resistance, Multiple, Bacterial
1Extensively Drug-Resistant Tuberculosis (blood)
1Extensively Drug-Resistant Tuberculosis (complications)
1Extensively Drug-Resistant Tuberculosis (diagnosis)
1Extensively Drug-Resistant Tuberculosis (epidemiology)
1Extensively Drug-Resistant Tuberculosis (microbiology)
1Follow-Up Studies
1HIV
1HIV (genetics)
1HIV (isolation & purification)
1HIV Infections (blood)
1HIV Infections (microbiology)
1HIV Infections (mortality)
1Infant
1Infant, Newborn
1Kaplan-Meier Estimate
1Lymph Nodes (microbiology)
1Microbial Sensitivity Tests
1Mycobacterium tuberculosis (drug effects)
1Patient Compliance (statistics & numerical data)
1Pleural Effusion (microbiology)
1RNA, Viral (blood)
1Research Support as Topic
1Retrospective Studies
1Risk Factors
1South Africa (epidemiology)
1Sputum (microbiology)
1Tuberculosis (complications)
1Tuberculosis (mortality)
1Tuberculosis, Pulmonary (complications)
1Tuberculosis, Pulmonary (epidemiology)
1Tuberculosis, Pulmonary (prevention & control)
1Viral Load
1World Health Organization

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/RSA/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i -k "Gerald Friedland" 
HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i  \
                -Sk "Gerald Friedland" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/RSA/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    RSA
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Gerald Friedland
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024